Compare Celestica Inc (CLS) vs Levi Strauss & Co. (LEVI) Price & Performance

Celestica (CLS) trades at $345.18, down 4.08% over 24 hours, with technical indicators showing a bearish trend near key support at $339. The company demonstrates strong fundamentals with Q1 2026 EPS of $2.16 beating estimates, revenue growth accelerating to 55.55% YoY, and a robust ROE of 52.45%. Recent leadership appointments and raised FY2026 revenue guidance to $19 billion reflect operational momentum amid AI and data center demand tailwinds.

Wall Street maintains a bullish outlook with 63% buy ratings and a $440.10 consensus price target, implying 27% upside. Key risks include competitive pressures in the EMS sector and execution challenges in margin expansion. The stock's high P/E of 41.82 warrants monitoring, but earnings beats and institutional confidence support a positive investment case pending Q2 results on July 28, 2026.

Levi Strauss (LEVI) trades at $24.19, down 0.49% on the day, with a neutral technical signal and strong fundamentals. The company reported Q2 2026 EPS of $0.28, beating estimates of $0.24, and raised full-year guidance. Revenue grew 7.6% year-over-year to $1.56B, driven by direct-to-consumer strength. Valuation metrics show a P/E of 17.28 and P/S of 1.45, with robust profitability including a 61.72% gross margin and 9.66% net margin.

Outlook remains positive with 83% analyst buy ratings and a $28 consensus price target, implying 16% upside. Risks include tariff pressures and foreign exchange volatility noted in recent earnings. The dividend was increased to $0.16, supporting income investors. Continued execution on digital strategy and product expansion provides growth catalysts amid competitive apparel markets.